Leading Healthcare Artificial Intelligence Company Raises $20m Series A Extension
prweb.com
news
2022-06-03 16:00:00

'EnsoData and its impactful technology represent an opportunity to improve the experience of treatment for patients and providers and accelerate big-picture shifts by opening greater access to diagnosis." MADISON, Wis. (PRWEB) June 03, 2022 EnsoData, the leading AI health care company helping clinicians uncover disease while patients sleep, today announces the closing of a $20 million Series A extension led by Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), with participation from existing investors including Zetta Venture Partners, Venture Investors, Supermoon Capital, Colle Capital, HealthX Ventures, M25 Ventures, Board members Justin Mortara, ​​Fred Robertson, MD, and other investors.
